The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours
- 31 July 2006
- journal article
- Published by Elsevier BV in Journal of Structural Biology
- Vol. 155 (1), 38-44
- https://doi.org/10.1016/j.jsb.2006.01.011
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexesBiochemical Pharmacology, 2005
- Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour modelsBiochemical Pharmacology, 2004
- The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cellsJBIC Journal of Biological Inorganic Chemistry, 2003
- XANES Determination of the Platinum Oxidation State Distribution in Cancer Cells Treated with Platinum(IV) Anticancer AgentsJournal of the American Chemical Society, 2003
- Hard X-ray microprobe studies of chromium(VI)-treated V79 Chinese hamster lung cells: intracellular mapping of the biotransformation products of a chromium carcinogenJBIC Journal of Biological Inorganic Chemistry, 2002
- Studies of the binding of a series of platinum(IV) complexes to plasma proteinsJournal of Inorganic Biochemistry, 2002
- Modifying the properties of platinum(IV) complexes in order to increase biological effectivenessJournal of Inorganic Biochemistry, 1999
- In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473.British Journal of Cancer, 1998
- The influence of structure on the activity and toxicity of Pt anti-cancer drugsCoordination Chemistry Reviews, 1997